Results 61 to 70 of about 1,519,876 (263)

Premium Subsidies and Social Insurance: Substitutes or Complements? [PDF]

open access: yes
Premium subsidies have been advocated as an alternative to social health insurance. These subsidies are paid if expenditure on health insurance exceeds a given share of income.
Kerstin Roeder, Mathias Kifmann
core  

Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus

open access: yesArthritis Care &Research, EarlyView.
Objective Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined the following: (1) associations between economic insecurities and PROs, and (2) the impact of screening and addressing economic ...
Jay Patel   +8 more
wiley   +1 more source

Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies

open access: yesBiomarker Research, 2020
Background For the detection of malignant mesothelioma additional markers are needed besides the established panel consisting of calretinin and mesothelin. The aim of this study was the identification and verification of long non-coding RNAs (lncRNAs) as
Daniel G. Weber   +11 more
doaj   +1 more source

An All‐Optical Driven Bio‐Photovoltaic Interface for Active Control of Live Cells

open access: yesAdvanced Functional Materials, EarlyView.
Bio‐photovoltaic Interface (BIO‐PV‐I) for live cell manipulation is presented. BIO‐PV‐I can be activated non‐invasively and remotely to control the spatial motility, adhesion, and morphology of cells adhering to it. BIO‐PV‐I uses a patterned light‐induced electric potential in iron‐doped lithium niobate crystals whose light‐driven and reversible nature,
Lisa Miccio   +8 more
wiley   +1 more source

EMA approved orphan medicines since the implementation of the orphan legislation

open access: yesOrphanet Journal of Rare Diseases
Background In the European Union (EU), the orphan legislation, aiming to increase the number of pharmacotherapies available for rare diseases, came into force in April 2000. This study examined the development of the selection of orphan medicines granted
Eveliina Hahl   +4 more
doaj   +1 more source

The Adjustment of the Romanian Public Pension Plan in the Context of European Integration [PDF]

open access: yes
The EU expansion process is a dynamic one which requires the candidate country to acknowledge the latest developments in communitarian social policy. The dominant economic aspects are currently reinforced by the social ones.
Stegaroiu, Valentin
core   +1 more source

A Soft Robotic Device for Targeted Massage Therapy of Residual Limbs

open access: yesAdvanced Robotics Research, EarlyView.
Residual limb edema after amputation can hinder recovery and delay prosthetic fitting. This study presents a soft‐robotic wearable device that delivers sequential compression through pneumatic McKibben actuators. By replicating the principles of manual lymphatic drainage, the device generates controlled mechanotherapeutic pressure patterns, providing a
Maria Grazia Polizzotto   +5 more
wiley   +1 more source

The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in Austria

open access: yesChild and Adolescent Psychiatry and Mental Health
Background The COVID-19 pandemic has impacted many aspects of everyday life, including the (mental) healthcare system. An increase in depression and anxiety symptoms has been reported worldwide, and is particularly pronounced in females and young people.
M. Otter   +4 more
doaj   +1 more source

MVP Inhibits Influenza A Virus‐Induced Ferroptosis by Targeting IRF1 and Increasing FSP1 Activity

open access: yesAdvanced Science, EarlyView.
During IAV infection, MVP inhibits IRF1 polyubiquitination, thereby relieving IRF1‐mediated transcriptional inhibition of FSP1. Consequently, this leads to an upregulation of FSP1 expression, thereby reinforcing the inhibition of ferroptosis. In addition, the MVP can promote myristoylation and ubiquitination of FSP1, enabling its membrane localization ...
Yingbo Chen   +12 more
wiley   +1 more source

The Difference of Satisfaction Level in BPJS Health Insurance Patient and Non Insurance Patient Toward Health Service [PDF]

open access: yes, 2016
National Health Insurance (JKN) developed in Indonesia is part of the National Social Insurance System (SJSN). One way to assess the services quality is to measure the patient satisfaction level.
Dewi, A. (Arlina)   +1 more
core  

Home - About - Disclaimer - Privacy